NCT00669916View on ClinicalTrials.gov

A Study Comparing AIN457 to Placebo in Subjects With a Diagnosis of Moderate to Severe Stable Plaque Psoriasis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
Plaque Psoriasis
Interventions
BIOLOGICAL

AIN457

single infusion of 3 mg/kg

DRUG

Placebo

single infusion of placebo

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY